Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-154-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
In vitro gene mutation in bacteria (Ames test): negative
In vitro micronucleus test: negative
In vitro gene mutation in mammalian cells: in progress
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Negative
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Ames test
This study was performed to evaluate the mutagenic activity of the test substance using the bacterial reverse mutation test on five histidine deficient mutant tester strains of Salmonella typhimurium (i.e., TA1537, TA1535, TA98, TA100, and TA102).
The test item was tested in two independent experiments in the absence and presence of metabolic activation. Bacterial cultures were exposed to the test item at 8 concentration levels (two plates/concentration) ranging from 1.5 to 5000 µg/plate in the initial toxicity-mutation test, using the plate incorporation method.
Normal bacterial background lawn was observed up to the concentration of 5000 µg/plate, in all tester strains (TA1537, TA1535, TA98, TA100, and TA102) in the absence and presence of the metabolic activation system (5% v/v S9 mix).
No increase in the number of revertant colonies (no mutagenic effect) was observed in the absence and presence of the metabolic activation system (5% v/v S9 mix) in any tester strain. To confirm the negative results obtained in the initial toxicity mutation test, the confirmatory mutation test was conducted, using the plate incorporation method with an increased S9 concentration, i.e., 10% v/v S9 mix and concentration spacing modification.
Bacterial cultures were exposed to the test substance at 6 concentration levels (three plates/concentration) ranging from 156.25 to 5000 µg/plate for tester strains TA1537, TA1535, TA98, TA100, and TA102 in the absence and presence (10 % v/v S9 mix) of the metabolic activation. The revertant colonies were scored after 48 hours of incubation at 37 ± 1 °C.
The test item did not induce any significant increase in the number of revertants, in trials with and without S9 mix, in any tester strain. Values for the negative control were within the historical control ranges of the laboratory. Positive controls showed an increase in the number of revertant colonies, demonstrating the efficiency of the test system.
All criteria for a valid study were met. Based on the results of this study, under specified experimental conditions, the test substance is concluded to be non-mutagenic in the Bacterial Reverse Mutation Test using Salmonella typhimurium.
In vitro micronulceus test
The evaluation of the chromosome damaging potential of In Vitro Mammalian Cell Micronucleus test of the test substance in Human Peripheral Blood Lymphocytes.
The substance was tested in two independent experiments, in the absence and presence of metabolic activation (2% v/v S9 mix), at selected concentrations based on results of cytotoxicity test. In the main study, human peripheral blood lymphocyte cultures were exposed to the test item at 6 concentrations from 62.5 to 2000 µg/mL (two cultures/dose level) in culture medium, in the absence and presence of metabolic activation system. The main study was conducted in two phases with lymphocytes exposed for 4 hours (with and without metabolic activation) as Phase I, and for 24 hours exposure (without S9) as Phase II. Following the consideration of the replicative index data, three concentrations of the test item were selected for micronucleus frequency analysis.
The test item did not induce either a statistically significant or biologically relevant increase in the number of binucleated cells with micronuclei, in the absence and presence of the metabolic activation, in either independently conducted experiment. The positive controls (cyclophosphamide and vinblastine) induced a statistically significant increase in the number and frequency of micronucleated binucleate cells and all criteria for a valid study were met.
From results of this study, it is concluded that the test substance did not induce micronuclei in isolated cultured human peripheral blood lymphocytes, when tested up to the concentration of 2000 µg/mL short term Phase I (in the absence and presence of metabolic activation (2% v/v S9 mix)) and in absence of metabolic activation at 2000 µg/mL at 24 h (long term -Phase II), under the described experimental conditions.
Additional information from genetic toxicity in vivo:
There are two in vivo mouse micronucleus studies for the hydrotropes – sodium cumene sulphonate (CAS 28348-53-0) (Sasol, 1992) and calcium xylene sulphonate (CAS 28088-63-3) (Ruetgers-Nease, 1994). Both are GLP-compliant Guideline mouse micronucleus studies with full documentation. The Sasol study was an oral dose of 4467 mg/kg bw and the Ruetgers-Nease study was an IP injection exposure of up to 580 mg/kg bw. All studies conclude the test substances were not mutagenic in these assays.
Justification for classification or non-classification
No conclusion on the mutagenicity of the substance can be currently drawn as the the gene mutation test in mammalian cells is still in progress
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.